NeuroBo submits IND to FDA for DA-1726 for the treatment of obesity
NeuroBo Pharmaceuticals has submitted an Investigational New Drug (IND) application to the FDA to support a Phase 1 clinical trial of...
top of page
Browse by category
Search
Browse by tag
bottom of page